PEN
Penumbra Inc
NYSE: PEN · HEALTHCARE · MEDICAL DEVICES
$326.48
+0.51% today
Updated 2026-04-30
Market cap
$12.79B
P/E ratio
71.96
P/S ratio
9.11x
EPS (TTM)
$4.53
Dividend yield
—
52W range
$221 – $362
Volume
0.6M
Penumbra Inc (PEN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.40M | $-6.39M | $-22.28M | $-12.81M | $12.69M | $28.81M | $26.65M | $-33.24M | $9.50M | $-55.66M | $97.33M | $168.48M | $238.66M |
| Capital expenditures | $798000.00 | $3.89M | $5.47M | $13.63M | $15.03M | $9.60M | $22.11M | $24.76M | $21.18M | $19.30M | $15.21M | $21.18M | $63.73M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $886000.00 | $1.43M | $7.27M | $14.64M | $17.81M | $18.42M | $21.48M | $25.54M | $65.76M | $37.38M | $50.52M | $46.16M | $59.21M |
| Free cash flow | $-4.19M | $-10.28M | $-27.75M | $-26.44M | $-2.34M | $19.20M | $4.54M | $-58.00M | $-11.68M | $-74.96M | $82.12M | $147.30M | $174.93M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | — | $18.54M | $10.07M | $15.83M | $8.04M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $16.26M | $-6.31M | $37.40M | $17.21M | $-48.32M | $-2.47M | $-11.40M | $10.75M | — | — | — |